RORA and prostate carcinoma: The EVs were taken up by prostate cancer cell lines, and functional in vitro analysis confirmed the regulation of RORA by the identified EV-miRNAs, resulting in dysregulation of proliferation and inflammation, and linking PPAT with prostate cancer aggressiveness.